| 000 | 01691 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517053622.0 | ||
| 264 | 0 | _c20160706 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a2299-5684 | ||
| 024 | 7 |
_a10.1016/j.pharep.2015.01.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMahmoudabady, Maryam | |
| 245 | 0 | 0 |
_aThe effect of angiotensin-converting enzyme inhibition on inflammatory and angiogenic factors in hypercholesterolemia. _h[electronic resource] |
| 260 |
_bPharmacological reports : PR _cOct 2015 |
||
| 300 |
_a837-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenic Proteins _xmetabolism |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCaptopril _xpharmacology |
| 650 | 0 | 4 |
_aCholesterol, Dietary _xmetabolism |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitric Oxide _xblood |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xmetabolism |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 700 | 1 | _aKazemi, Narges | |
| 700 | 1 | _aNiazmand, Saeed | |
| 700 | 1 | _aRezaee, Seyyed Abdolrahim | |
| 700 | 1 | _aSoukhtanloo, Mohammad | |
| 700 | 1 | _aHosseini, Mahmoud | |
| 773 | 0 |
_tPharmacological reports : PR _gvol. 67 _gno. 5 _gp. 837-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pharep.2015.01.008 _zAvailable from publisher's website |
| 999 |
_c25287913 _d25287913 |
||